How Much Did WARD 24/7 Raise?
Funding & Key Investors

WARD 24/7, a Copenhagen-based innovator in the medical technology sector, has successfully secured a significant capital infusion to accelerate its mission of transforming patient monitoring. The company recently finalized a major strategic investment, bringing its total funding to $4.1M. This latest financing round, totaling $4.1M, underscores the growing market confidence in AI-driven healthcare solutions and positions the firm for substantial operational expansion within the European medtech landscape.

What is WARD 24/7?

WARD 24/7
ManufacturingMedical Devices & EquipmentHealthcare Software

Operating at the intersection of artificial intelligence and clinical care, WARD 24/7 provides sophisticated patient monitoring systems designed to enhance diagnostic accuracy and patient outcomes. By leveraging advanced data analytics, the company addresses critical gaps in hospital-based monitoring, offering real-time insights that empower medical professionals to make informed decisions. As a key player in the Danish health-tech ecosystem, WARD 24/7 is effectively bridging the gap between complex algorithmic processing and practical, bedside clinical application, thereby setting a new standard for continuous patient surveillance in high-acuity environments.

How much funding has WARD 24/7 raised?

WARD 24/7 has raised a total of $4.1M across 1 funding round:

2024

Other Financing Round

$4.1M

Other Financing Round (2024): $4.1M with participation from Danish Export and Investment Fund, Sagitta Ventures, and Innovestor

Key Investors in WARD 24/7

Danish Export and Investment Fund

A state-backed investment entity focused on fostering economic growth and supporting Danish enterprises with significant market potential.

Sagitta Ventures

A venture capital firm providing strategic backing to high-growth technology companies.

Innovestor

A Finnish investment manager specializing in early-stage technology and life science startups, with a focus on driving positive economic impact.

What's next for WARD 24/7?

With this major enterprise-level funding, WARD 24/7 is poised to scale its technological infrastructure and broaden its market reach. The strategic allocation of this capital will likely focus on enhancing the robustness of its AI models, securing regulatory milestones in international markets, and scaling its commercial operations to meet the rising demand for digital health integration. As the company transitions into this next phase of growth, the focus will remain on maintaining clinical efficacy while optimizing the scalability of its monitoring platform to support healthcare providers globally.

See full WARD 24/7 company page
See More Financial Insights
No matching results.
Refine your search.

Additional financial insights in the Manufacturing industry

Health & Nutrition ProductsManufacturingRetailVitamins, Supplements & Health Stores
FurnitureManufacturingRetail
ElectronicsManufacturing
ManufacturingTextiles & ApparelFurnitureRetail

Frequently Asked Questions Regarding WARD 24/7 Financial Insights

What are the most recent funding rounds that WARD 24/7 has completed, and what were the funding rounds?
WARD 24/7 has recently completed 1 funding rounds: Other Financing Round on Jan 26, 2024.
What is the total amount of funding WARD 24/7 has raised to date?
WARD 24/7 has raised a total of $4.1M in funding to date.
How many funding rounds has WARD 24/7 completed?
WARD 24/7 has completed 1 funding rounds.
How much funding did WARD 24/7 raise in its most recent funding round?
WARD 24/7 raised $4.1M in its most recent funding round.
Who are the lead investors in WARD 24/7's latest funding round?
The lead investor in WARD 24/7's latest funding round was Danish Export and Investment Fund. To access investor data and explore similar companies, sign up for ZoomInfo.
Which was the largest funding round in WARD 24/7's history?
The largest funding round in WARD 24/7's history was $4.1M.
See more information about WARD 24/7